Ceramides versus standard methods in prediction of subclinical atherosclerosis

Read full text Summarise with VIRAT
Authors: Janula Stromská, Geraldo T. G. Neto, Irma Magaly Rivas‐Serna, Juan Pablo Gonzalez-Rivas, Manlio Vinciguerra, Roman Panovský, Radim Brát, Jiří Plášek
Cited by: 0
References: 36

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Ceramides are a heterogeneous group of bioactive membrane sphingolipids that play specialized regulatory roles in cellular metabolism depending on their characteristic fatty acyl chain lengths and subcellular distribution. Ceramides have emerged as promising biomarkers for cardiovascular diseases. METHODS: Within the prospective Kardiovize study based in Brno, Czech Republic, we aimed to develop two carotid intima-media thickeness (CIMT) prediction models using available variables. One model incorporated, in addition to sex and age, conventional biomarkers (total cholesterol, triglycerides, lipid-lowering therapy), while the other included blood concentrations of selected ceramides. Lipids species were measured by a hyphenated mass spectrometry technique. RESULTS: A total of 139 men (mean age 61.8 ± 16.4) and 222 women (63.9 ± 14.8) were included in the present study. Both approaches yielded almost identical coefficients of determination (54.6 % vs 55.0%) with good classification abilities (weighted kappa 0.69 vs 0.71) in both models. The ceramide (d18:1/18:0) shows a strong negative association with CIMT (β = -1.39, P=0.04), while (d18:1/24:1) shows a positive association with carotid intima-media thickness (β=0.20, P=0.002). CONCLUSION: The tested ceramides were able to predict subclinical atherosclerosis by carotid intima-media thickness with comparable accuracy to a combination of routinely tested lipids.

Fields of Study & Subjects

Sphingolipid Metabolism and Signaling Diabetes Cardiovascular Risks and Lipoproteins Lipoproteins and Cardiovascular Health

Publication details

Journal / source
Biomedical Papers
Volume
170
Issue
2
Pages
123–130
Publication date
25 March 2026
Language
EN